GlaxoSmithKline Sues Moderna Over Alleged Violations Of Patent Rights Regarding mRNA Technology In COVID-19 Vaccine

Reuters (10/15, Brittain) reports, “GlaxoSmithKline sued Moderna in U.S. federal court in Delaware on Tuesday, accusing its American rival of violating GSK’s patent rights in messenger RNA (mRNA) technology with its blockbuster COVID-19 vaccine Spikevax.” According to a pair of “lawsuits, Moderna’s lipid nanoparticles for transporting fragile mRNA into the human body infringe several GSK patents covering similar innovations.” The “litigation seeks unspecified monetary damages.”